Author: Healthcare Propulsion Staff

Oxford University researchers have captured the step-by-step assembly of individual virus-like particles, revealing how simple molecular interactions can reliably build these complex biological structures. The results have been published today (16 September) in Nature. Understanding how viruses assemble – and what can disrupt this process – could ultimately help researchers design novel antiviral treatments, as well as engineer vaccines and other therapies. The new study provides a molecular-level view of how the protein shells associated with viruses can spontaneously and reliably assemble from their individual components, even when there are thousands of possible ways for these to fit together. The…

He took a job at a hospital undergoing a billing system implementation.  “My two work streams crossed and I wound up in the healthcare industry,” he reflects. “That was in 1984.”  Since then, Jeff has worked exclusively in health systems, including as a Partner at EY and a Managing Director at Deloitte – both Big Four professional services firms. He joined Rush in 2021, following what he describes as a pivotal, pandemic-driven moment of reflection.  “I was ready to be part of a team – watching it grow, developing it, taking on new challenges,” continues Jeff. “Ultimately, consulting is not…

Zocdoc, the marketplace for booking provider visits, is making its infrastructure available to enterprise partners to support bookings anywhere patients look for care.  The new enterprise offering, Care Access Network, invites payers and tech or consumer platforms to deliver seamless booking directly on their websites. The infrastructure is built on two decades of connecting provider orgs, payers, electronic health records (EHRs) and practice management systems with scheduling workflows. Zocdoc’s marketplace today connects to over 200,000 providers across over 200 specialties and 10,000 plans.  “I’m incredibly proud of the door we built with Zocdoc.com, but I’ve come to the conclusion that…

Not-for-profit health system Sentara Health is moving beyond administrative automation to test artificial intelligence-powered clinical care directly during primary care visits. The health system is working with GW RhythmX, a health AI and patient engagement company, to roll out a pilot program testing AI-powered precision care within clinician workflows. GW RhythmX, formed through the 2025 merger of RhythmX AI and Get Well, offers generative and predictive AI-powered assistants that support physician decision-making. The company says its precision care platform provides relevant clinical, operational and patient-specific insights at the point of care, helping clinical care teams deliver more personalized and coordinated care…

ZEISS today introduced ZEISS VersaXRM 5 Insight, a hybrid 3D X-ray microscope designed to help researchers and engineers understand samples faster. Combining X-ray microscopy and microCT in a single platform, the system delivers multi-scale imaging, guided workflows, and automated AI-enabled reconstruction for efficient non-destructive 3D imaging. Built for performance and engineered for value, ZEISS VersaXRM 5 Insight helps researchers and engineers in materials research, industrial inspection, and life sciences reduce tradeoffs between throughput, resolution, and usability. ZEISS VersaXRM 5 Insight hybrid 3D X-ray microscope enables efficient, insight-drive workflows by combining multi-scale imaging, guided workflows based on human-centered design principles, and…

Dizziness, fatigue, brain fog and a racing heart. They’re commonly associated with Long COVID, but new Adelaide University research suggests that for some people, these symptoms may also be indications of Postural orthostatic tachycardia syndrome (POTS), a debilitating and difficult-to-diagnose condition. Conducted in partnership with SAHMRI, the study compared heart rate changes, symptoms and immune profiles among people with POTS, Long COVID and healthy participants, finding that almost two-thirds (62.5%) of the Long COVID participants also met the diagnostic criteria for POTS. It’s an important finding that could help explain some of the symptoms experienced by people with Long COVID…

The cancer journey for many patients doesn’t end after treatment. Many live with long-term side effects that affect their ability to sleep and cause pain, impacting daily life. A new study in the Journal of Clinical Oncology finds mindfulness and tai chi practices can help cancer survivors manage those symptoms.  The Mindfulness and Tai Chi for Cancer Health (MATCH) study looked at over 500 cancer survivors with varying types and stages of cancer and found that patients experienced less pain, fatigue, and sleep problems after participating in the interventions. The study, which was published in the Journal of Clinical Oncology,…

The diabetes drugs glucagon-like peptide-1 (GLP-1) receptor agonists and sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs may also help to slow decline in kidney function in people with type 2 diabetes and albuminuria (high protein levels in the urine), finds a large US study published by The BMJ today. However, for those without albuminuria, other diabetes drugs (sulfonylureas) led to faster decline in kidney function, highlighting the importance of considering albuminuria when making treatment decisions, say the authors. Previous studies have shown that GLP-1 receptor agonists and SGLT-2 inhibitors can lower the risk of chronic kidney disease (CKD) progression in…

“I have seen such a huge change in my own physique and my capabilities – I am sure that my body is at least 20 years younger,” she told BBC CWR.”When they invited me to the British and European Championships, I thought, ‘Well I have been invited it would be rude not to go’, but who thought it would lead to this? I didn’t,” she said.Barons said her journey, down to hard work and dedication over the past couple of years, has been “so exciting”.”I have learnt so much, I have met people all around the world, and it has…

A groundbreaking study reveals that your genes may make you more vulnerable to Post Traumatic Stress Disorder (PTSD) from certain types of trauma-particularly childhood neglect-than from others.  The peer-reviewed findings, published today in the European Journal of Psychotraumatology, suggest that both what happens to you and your genetic makeup together affect your risk of developing the disorder.  PTSD; and who might be more vulnerable?  In the wake of a life-threatening event (trauma), many people experience strong emotional or physical reactions. These reactions can be overwhelming, but for most people they gradually ease over time. When they endure and begin to…